Esmail Riahi

Dr. Esmail Riahi


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 December 2013 in Neuropharmacology
Verified
Journal Article
Closed access
Giulia PonterioGiulia Ponterio
Giulia Ponterio
Annalisa TassoneAnnalisa Tassone
Annalisa Tassone
GSG. Sciamanna
G. Sciamanna
EREsmail Riahi
Esmail Riahi
VVV. Vanni
V. Vanni
Antonio PisaniAntonio Pisani
Antonio Pisani

18 June 2011 in Clinical Oral Investigations
Verified
Journal Article
Closed access
PDF file
IMIraj Mirzaii-Dizgah
Iraj Mirzaii-Dizgah
SHSeyed Fakhreddin Hejazi
Seyed Fakhreddin Hejazi
EREsmail Riahi
Esmail Riahi
MSMohammad Mohsen Salehi
Mohammad Mohsen Salehi

1 October 2012 in Peptides
Verified
Journal Article
Closed access
ZTZahra Taslimi
Zahra Taslimi
RAReza Arezoomandan
Reza Arezoomandan
AOAlireza Omranifard
Alireza Omranifard
MGMohadeseh Ghalandari-Shamami
Mohadeseh Ghalandari-Shamami
EREsmail Riahi
Esmail Riahi
Abbas HaghparastAbbas Haghparast
Abbas Haghparast

1 March 2015 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
EREsmail Riahi
Esmail Riahi
RAReza Arezoomandan
Reza Arezoomandan
ZFZahra Fatahi
Zahra Fatahi
Abbas HaghparastAbbas Haghparast
Abbas Haghparast

1 August 2013 in Behavioural Pharmacology
Verified
Journal Article
Closed access
EREsmail Riahi
Esmail Riahi
FKFariba Khodagholi
Fariba Khodagholi
Abbas HaghparastAbbas Haghparast
Abbas Haghparast
In this study, we evaluated the role of orexin receptors in the dorsal hippocampus (dHPC) in the development of morphine-induced conditioned place preference (CPP) and modification of hippocampal c-Fos and cyclic AMP response element-binding protein (CREB) levels. Orexin-A (0.5, 5, and 50 pmol) and the orexin-1 receptor antagonist, SB334867 (10, 20, and 40 nmol), were bilaterally infused into the dHPC immediately before conditioning with morphine (0.5 or 7.5 mg/kg) using the CPP task. Western blotting was then used to measure the protein levels of c-Fos, total CREB, and phosphorylated CREB (pCREB) in the hippocampus. Orexin did not enhance the rewarding efficacy of morphine (0.5 mg/kg), but caused a reduction in hippocampal c-Fos. Successful conditioning with morphine (7.5 mg/kg) was associated with increased levels of hippocampal c-Fos and CREB, but with decreased CREB phosphorylation. Intrahippocampal administration of SB334867 before conditioning sessions disrupted the rewarding effect of morphine (7.5 mg/kg) and blocked morphine-induced increases in hippocampal CREB protein levels. The results suggest that orexin signaling within the dHPC is necessary for the development of morphine CPP. Morphine reward is related to altered levels of hippocampal c-Fos and CREB. Inhibition of morphine-induced increases in CREB levels might be the underlying mechanism for the disruption of morphine CPP.